ET
Exin Therapeutics, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$2.2Msold at filing
Total offering$2.2M
Investors in the raise28count reported to the SEC
FiledFeb 10, 2026first sale Nov 18, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gabriel Ocana SanteroExecutive Officer, Director
Ivan Alex Priela LazarteExecutive Officer, Director
Marko TvrdicExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.